SummaryPharmacological modulators of host-microbial interactions can in principle be identified using high-content screens. However, a severe limitation of this approach is the lack of insights into the mode of action of compounds selected during the primary screen. To overcome this problem, we developed a combined experimental and computational approach. We designed a quantitative multiparametric image-based assay to measure intracellular mycobacteria in primary human macrophages, screened a chemical library containing FDA-approved drugs, and validated three compounds for intracellular killing of M. tuberculosis. By integrating the multiparametric profiles of the chemicals with those of siRNAs from a genome-wide survey on endocytosis, we p...
Existing antibiotics are inadequate to defeat tuberculosis (TB), a leading cause of death worldwide....
Understanding how the host immune system signals in response to infection by pathogenic mycobacteria...
BACKGROUND: Antibiotic therapy targeting chronic mycobacterial disease is often ineffective due to p...
Pharmacological modulators of host-microbial interactions can in principle be identified using high-...
The stable infection of host macrophages by Mycobacterium tuberculosis (Mtb) involves, and depends o...
We performed a genome-wide siRNA screen to identify host factors that regulated pathogen load in hum...
SummaryWe performed a genome-wide siRNA screen to identify host factors that regulated pathogen load...
Tese de doutoramento, Farmácia (Biologia Celular e Molecular), Universidade de Lisboa, Faculdade de ...
SummaryWhereas intracellular carbon metabolism has emerged as an attractive drug target, the carbon ...
A critical feature of Mycobacterium tuberculosis, the causative agent of human tuberculosis (TB), is...
Most candidate anti-bacterials are identified on the basis of their whole cell anti-bacterial activi...
Mycobacterium tuberculosis remains a significant threat to global health. Macrophages are the host c...
The development of novel treatment against tuberculosis is a priority global health challenge. Antim...
A key to the pathogenic success of Mycobacterium tuberculosis (Mtb), the causative agent of tubercul...
Mycobacterium tuberculosis (MTB) remains a major challenge to global health made worse by the spread...
Existing antibiotics are inadequate to defeat tuberculosis (TB), a leading cause of death worldwide....
Understanding how the host immune system signals in response to infection by pathogenic mycobacteria...
BACKGROUND: Antibiotic therapy targeting chronic mycobacterial disease is often ineffective due to p...
Pharmacological modulators of host-microbial interactions can in principle be identified using high-...
The stable infection of host macrophages by Mycobacterium tuberculosis (Mtb) involves, and depends o...
We performed a genome-wide siRNA screen to identify host factors that regulated pathogen load in hum...
SummaryWe performed a genome-wide siRNA screen to identify host factors that regulated pathogen load...
Tese de doutoramento, Farmácia (Biologia Celular e Molecular), Universidade de Lisboa, Faculdade de ...
SummaryWhereas intracellular carbon metabolism has emerged as an attractive drug target, the carbon ...
A critical feature of Mycobacterium tuberculosis, the causative agent of human tuberculosis (TB), is...
Most candidate anti-bacterials are identified on the basis of their whole cell anti-bacterial activi...
Mycobacterium tuberculosis remains a significant threat to global health. Macrophages are the host c...
The development of novel treatment against tuberculosis is a priority global health challenge. Antim...
A key to the pathogenic success of Mycobacterium tuberculosis (Mtb), the causative agent of tubercul...
Mycobacterium tuberculosis (MTB) remains a major challenge to global health made worse by the spread...
Existing antibiotics are inadequate to defeat tuberculosis (TB), a leading cause of death worldwide....
Understanding how the host immune system signals in response to infection by pathogenic mycobacteria...
BACKGROUND: Antibiotic therapy targeting chronic mycobacterial disease is often ineffective due to p...